A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer
Abstract About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological and clinical factors are used to select patients f...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/9dd3caffa57b43dc8719f849893eb89b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|